Core Insights - Xishan Technology's stock closed at 62.75 yuan, up 1.29%, with a rolling PE ratio of 34.63 times and a total market value of 2.918 billion yuan [1] - The average PE ratio in the medical device industry is 48.90 times, with a median of 36.41 times, placing Xishan Technology at the 74th position [1] - As of the first quarter of 2025, eight institutions held shares in Xishan Technology, with a total holding of 6.3702 million shares valued at 416 million yuan [1] Company Overview - Chongqing Xishan Technology Co., Ltd. specializes in the research, development, manufacturing, sales, and service of surgical medical devices [1] - Key products include surgical power devices, endoscopic systems, and energy surgical equipment [1] - The company holds three Class III medical device registration certificates and 36 Class II medical device registration certificates, and has led the drafting of six national industry standards related to surgical power devices [1] - Xishan Technology has undertaken several national and local technology projects, including the "Twelfth Five-Year" National Science and Technology Support Program and various innovation and application demonstration projects [1] Financial Performance - For the first quarter of 2025, the company reported operating revenue of 65.8771 million yuan, a year-on-year decrease of 11.20%, and a net profit of 11.4768 million yuan, down 55.66% [2] - The sales gross margin stood at 67.64% [2] - The company's PE (TTM) is 34.63, while the industry average is 48.90 and the industry median is 36.41 [2]
西山科技收盘上涨1.29%，滚动市盈率34.63倍，总市值29.18亿元